SCHEMBL9628178

SCHEMBL9628178

COC1=C(c2ccccc2)C(=O)c2ccccc2C1=O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 10/20 1.00
ALDH1A1 P00352 4/20 1.00
MITF O75030 2/20 1.00
HTT P42858 1/20 1.00
NPSR1 Q6W5P4 1/20 1.00
PDE4B Q07343 2/20 0.77
TP53 P04637 4/20 0.65
CDC25A P30304 3/20 0.65
CDC25B P30305 3/20 0.65
SMN1; SMN2 Q16637 3/20 0.65
LMNA P02545 3/20 0.65
TDP1 Q9NUW8 3/20 0.65
POLB P06746 2/20 0.65
HPGD P15428 2/20 0.65
RAB9A P51151 2/20 0.65
KDM4E B2RXH2 2/20 0.65
MAP2K7 O14733 1/20 0.65
GMNN O75496 1/20 0.65
CYP1A2 P05177 1/20 0.65
CYP3A4 P08684 1/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5164345 0.83 PDE4B (0.83) MAPTALDH1A1MITFHTTNPSR1
SCHEMBL571557 0.80 MAPT (1.00) MAPTALDH1A1MITFHTTNPSR1
SCHEMBL29545010 0.80 MAPT (1.00) MAPTALDH1A1MITFHTTNPSR1
SCHEMBL5497788 0.80 MAPT (0.65) MAPTALDH1A1MITFHTTNPSR1
SCHEMBL25240605 0.79 ALDH1A1 (0.65) MAPTALDH1A1MITFHTTNPSR1
SCHEMBL20100968 0.77 MAPT (0.62) MAPTALDH1A1MITFHTTNPSR1
SCHEMBL5191181 0.77 ALDH1A1 (0.62) MAPTALDH1A1MITFHTTNPSR1
SCHEMBL9572026 0.77 ALDH1A1 (0.60) MAPTALDH1A1MITFHTTNPSR1
SCHEMBL740371 0.76 FGFR1 (0.61) MAPTALDH1A1MITFHTTNPSR1
SCHEMBL14773972 0.76 MAPT (0.59) MAPTALDH1A1MITFHTTNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5155132-A Nonsteroidal antiinflammatory agents; treating psoriasis SYNTEX (U.S.A.) INC. (US) 1992-10-13 US disclosed
US-5134161-A Enzyme inhibitors for skin disorders, antiinflammatory agents SYNTEX (U.S.A.) INC. (US) 1992-07-28 US disclosed
US-5091558-A Topical administeration SYNTEX (U.S.A.) INC. (US) 1992-02-25 US disclosed
US-5089657-A Topical antiinflammatory agents SYNTEX (U.S.A.) INC. (US) 1992-02-18 US disclosed
US-4786652-A TOPICAL ADMINISTRATION SYNTEX (U.S.A.) INC. (US) 1988-11-22 US disclosed
EP-0282006-A1 Naphtalene anti-psoriatic agents SYNTEX (U.S.A.) INC. (US) 1988-09-14 EP disclosed
EP-0282056-A2 Naphthalene anti-psoriatic agents SYNTEX (U.S.A.) INC. (US) 1988-09-14 EP disclosed
EP-0150831-B1 NAPHTHALENE ANTI-PSORIATIC AGENTS SYNTEX (U.S.A.) INC. (US) 1988-08-10 EP disclosed
US-4758587-A Naphthalene anti-psoriatic agents SYNTEX (U.S.A.) INC. (US) 1988-07-19 US disclosed
EP-0150831-A2 Naphthalene anti-psoriatic agents SYNTEX (U.S.A.) INC. (US) 1985-08-07 EP disclosed